Reading view
Design Guidelines for Online Health Forums: User-Centered Design Approach
Anonymization of Portuguese Clinical Notes Using Large Language Models and Quantum-Enhanced Hybrid Architectures: Comparative Evaluation Study
Digital Phenotyping of Lifestyle Profiles and Mental Well-Being in German Adults: Prospective Longitudinal Cohort Study
Java News Roundup: New OpenJDK JEPs, CDI 5.0, Spring, Open Liberty, RefactorFirst, ADK for Kotlin

This week's Java roundup for September 7th, 2026, features news highlighting: new JEPs for ahead-of-time compilation and structured concurrency; GA releases of Jakarta CDI 5.0 and ADK for Kotlin 1.0; the September 2026 edition of Open Liberty; point releases of TornadoVM and RefactorFirst; a maintenance release of Micronaut; and first releases candidates of Groovy 6.0 and Gradle 9.8.
By Michael RedlichAI infrastructure company Cornelis raises $205M to chip away at Nvidia’s dominance
Evaluation of the Square Eyes Model as a Screening Tool for Identifying Digital Technologies in Wearable Camera Images Among Children: Laboratory Study
First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval
(MedPage Today) -- The FDA approved apitegromab (Isembyld) injection to treat spinal muscular atrophy (SMA) in adults and pediatric patients ages 2 years and older who currently are receiving an SMN2-targeted treatment, the agency announced Friday... Amazon Prime Video takes on TikTok with short-form news clips
ClickFix attacks are tricking Mac and Windows users into hacking themselves
The AI industry has taken a doomer turn. What now?
This story appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here.
This weekend, Dario Amodei, CEO of Anthropic, posted an essay calling for a brake on the pace of development of LLMs. Amodei cites the looming dangers he sees from the technology, from its use in cyberattacks and bioterrorism to its potential to wreck the economy. The heads of the other three top US AI labs—OpenAI CEO Sam Altman, Google DeepMind chairman Demis Hassabis, and SpaceXAI CEO Elon Musk—voiced their support. “Dario is right,” Musk wrote on X.
Think about how surreal that agreement is for a moment. Just a few months ago, Musk and Altman sat in court attacking each other’s reputations in a (failed) lawsuit that Musk brought against his former OpenAI colleague that was—on paper at least—about whether or not Altman was a trustworthy steward of such dangerous technology.
Amodei’s rift with OpenAI is even deeper. Anthropic was founded in 2021 because Amodei didn’t think Altman took the risks of the technology they were building seriously enough. Anthropic and OpenAI have been competing in a winner-takes-all race ever since. (Hassabis has stayed out of the drama, but his company remains a rival.)
Now, it seems, they’re all in agreement: The latest generation of LLMs aren’t safe and everyone needs to figure out what to do about it. The public messaging from the top AI labs has taken a doomer turn.
It’s easy to be cynical. It’s not at all clear what any of them mean by a slowdown or how it would work. These companies also care a lot about how they come across. With trillion-dollar IPOs in their sights, OpenAI and Anthropic need to reassure investors that they’re the grown-ups in the room while at the same time hinting at the power of the monsters they have created—and intend to tame. Calling for a slowdown does both.
And yet the vibe at the top of these firms really does appear to have shifted. Amodei’s latest post landed six days after OpenAI published an essay by Jakub Pachocki, the firm’s chief scientist, in which he also laid out why he’s concerned about what will happen if the pace of development of LLMs continues unchecked. In short, Pachocki is worried that OpenAI’s ability to build powerful models now far outstrips its ability to monitor and control them.
Amodei and Pachocki each cite the cyberattack against AI firm Hugging Face by a swarm of OpenAI’s agents in July—a hack that OpenAI did not even realize had taken place until days after it was all over—as a wake-up call.
But their exact position is hard to pin down. Pachocki both calls for a slowdown and highlights an urgent need to stay ahead: “The strongest argument I see for continuing to train much smarter models quickly is the need to build defensive systems against the dangers posed by other AI,” he writes. As Pachocki frames it, AI firms are locked in a literal arms race. Slowing down is good, winning is better.
(Don’t forget: OpenAI just spent millions of dollars and a staggering amount of computer power to rush out a controversial math result a few days ahead of Anthropic.)
But let’s assume a slowdown happens. Top labs agree to spend more time and resources on finding ways to monitor and control existing models instead of making more capable ones. They invite outside auditors in to help evaluate those models.
What might this coordinated effort actually achieve? Consider the Hugging Face attack again. OpenAI has said that the model that drove most of the rogue agents was a “highly persistent” next-generation model that it was testing in-house. The implication is that OpenAI has built a model so good it’s dangerous.
But if you read the reports about the Hugging Face hack published by OpenAI and METR, a third-party firm that OpenAI called in to help them understand what happened, what you come away with is the impression not of a model that was too powerful for OpenAI to keep up with, but of a broken model that OpenAI failed to train properly.
The agents did what they did—including leaving messages for one another, delegating work to other agents, and scouring their environment for any means possible to complete their tasks—because they had been rewarded during training for doing exactly those things. There were also errors in the training setup, such as tasks that were impossible to complete, which pushed the models to find unexpected workarounds that were also rewarded. At the time, many of these issues went overlooked or unreported.
OpenAI says it has stopped training this new model and locked it down. That makes it sound like it has caged a dangerous beast. In fact, OpenAI has shelved a faulty product.
That’s not to say a faulty product can’t be dangerous. Broken software has even killed people in the past. But as the discussion of a slowdown gathers steam, it’s worth remembering that all of this is self-inflicted. A slowdown might have some altruistic side effects. But it’ll mostly give these tech titans a chance to clean up the mess on their own assembly lines.
Transparency from these frontier labs will be key to any meaningful effort to reform, restrain, or regulate AI. Otherwise, the rest of us will still only have their word for exactly what they’ve built and how safe it is—whatever pace they’re going.
To continue this discussion about AI’s latest doomer moment, join me and my colleagues for a subscriber-exclusive Roundtable discussion tomorrow, September 15, at 11 a.m. US eastern time. We hope to see you there!
Volkswagen’s crazy-efficient EV borrows an idea from Slate
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
(MedPage Today) -- Brain MRI surveillance without prophylactic cranial irradiation (PCI) led to improved cognitive failure-free survival (CFFS) in patients with small cell lung cancer (SCLC), the phase III MAVERICK trial showed.
Patients randomized... With iOS 27, I’m actually using Siri again
macOS 27: new Siri takes on AI productivity apps
Fashion app Daydream uses Apple Intelligence to help you shop the outfits in your camera roll
Preserving Muscle During GLP-1 Weight Loss
(MedPage Today) -- Blockbuster GLP-1 receptor agonists revolutionized obesity management in recent years, driving weight loss of up to 20%.
This weight loss, however, can carry a notable downside: Studies estimate that 15% to 40% of GLP-1-induced... $500 Obamacare Rebates Are Legally Precarious. And Do Nothing for Healthcare Costs.
(MedPage Today) -- The Trump administration's announcement that it will send $500 "rebate" checks to roughly 1 million Affordable Care Act (ACA) enrollees in 30 states ($500 million total) fits a familiar pattern: seeking political advantage through...